Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
Our Next Event → LSI USA '24 in Dana Point, California on March 18-22.
Hear from the LSI Alumni community on why they attend (and come back to) LSI events.
This special panel features Manny Villafaña, a highly successful Medtech executive with seven IPO's, who discusses his current venture, his start in the med device world, and the stories that improved the lives of patients globally.
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
Wander Health's digital platform is designed to connect travelers with English-speaking healthcare providers across the globe.
In this discussion, the panelists provide a comprehensive perspective from all sides of an acquisition, offering a roadmap for navigating the complexities of these business transactions.
AVVie is developing a novel, minimally invasive implant to address mitral valve regurgitation.
With AI and Large Language Models currently experiencing widespread implementation, this timely panel reviews their impact and opportunity in Healthcare.
Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia.
This panel explores the impact of the digital transformation in healthcare and hospitals, while also discussing the opportunities and challenges presented.
Through this panel, our panelists showcase Barcelona's Life Science ecosystem, delving into its strengths, weaknesses, and unique advantages in fostering innovation.
The panelists discuss the process and pitfalls of operating, investing in, or commercializing a digital health/therapeutics startup.
This panel aims to guide pre-commercial and commercial stage startups in successfully entering their first hospital and how to navigate the path to further expansion.
This 'Tale of Two Entrepreneurs' explores the shift from an entrepreneurial background to venture capital, while highlights its significance in building an early-stage VC.
This discussion will review and assess the evolving trends within the healthtech, medtech, and biotech landscapes, exploring strategies to bolster these ecosystems amidst the prevailing investment climate.
During this insightful panel, industry experts explore the obstacles obstructing the aggregation of patient and EHR data, despite its potential to drive innovation and personalize healthcare.
Intuitive Ventures invests in and accelerates the digital, therapeutic, diagnostic, and device ecosystems of minimally invasive care.
This panel talks about the transformative potential of the next generation of robotics and digital surgery, moving beyond mere gadgetry to unlock substantial real-world value.
In this discussion, panelist share their company's next generation innovations for digital surgery, as they look to set a new standard of care.
Asabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation.
This discussion delves into the strategies and factors that drive substantial advancements through a startup's growth stage.
In this session, seasoned life science investors explore alternative strategies for navigating market challenges, focusing on exit and scaling approaches.
This panel focuses on how to navigate the AI landscape in regards to the new Digital Medicine play in healthcare.
The company is developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
Murielle Thinard McLane sat down at LSI Europe ‘23 to discuss Intuitive Ventures' strategy and goals.
In this session, four distinct medtech innovators with data-driven business models discuss their approaches in navigating the new landscape of Digital Medtech.
The panel explores what four different strategics look for in a potential investment as well as how much they are willing to invest.
In this panel, five female executives share their insights and stories into what it means to be a female entrepreneur and why more diverse representation is necessary.
In this faintly controversial discussion, four neurotech executives from emerging startups talk about the current state of neurotech, how their solutions are pushing forward patient care, and the ethical concerns surrounding BCI and DBS.
We Venture Capital is investing globally in diagnostics start-ups, as well as digital solutions and biotechnology in the diagnostics arena.
